Recombinant Human SKP1-SKP2 Protein

SKP1 and SKP2 are crucial components of the SCF (SKP1-Cullin-F-box) E3 ubiquitin ligase complex, which plays a significant role in the regulation of protein degradation pathways through the ubiquitin-proteasome system. SKP1 serves as an adaptor protein that links F-box proteins, which recognize specific substrates, to the Cullin scaffold, thus facilitating the ubiquitination process. SKP2, an F-box protein, is known for its role in the cell cycle regulation by targeting the cyclin-dependent kinase inhibitor p27 for degradation, thereby promoting cell cycle progression and cellular proliferation. Dysregulation of SKP2 has been implicated in various cancers, making it a valuable target for therapeutic interventions. The study and characterization of SKP1-SKP2 recombinant proteins are essential for understanding the molecular mechanisms underlying their function in ubiquitination and cell cycle control. Researchers employ techniques like protein expression and purification to investigate the structural properties and interactions of these proteins, which can reveal potential drug targets or inform the development of inhibitors that disrupt abnormal protein degradation pathways in cancer. Overall, the exploration of SKP1-SKP2 recombination provides insights into the complex regulatory networks governing cellular processes and has significant implications for cancer therapy and other diseases related to protein homeostasis.